Astera Labs (ALAB) stock jumps nearly 8% as chip rally kicks off 2026

Astera Labs (ALAB) stock jumps nearly 8% as chip rally kicks off 2026

NEW YORK, Jan 2, 2026, 21:00 ET — Market closed

  • Astera Labs shares closed up 7.9% at $179.56 on Friday.
  • Chip stocks led the market higher, with the Philadelphia Semiconductor Index up 4%, Reuters reported. 1
  • Investors are eyeing January 9 U.S. jobs data and the start of fourth-quarter earnings season for the next catalyst. 2

Shares of Astera Labs closed up 7.9% on Friday at $179.56, lifting the Nasdaq-listed semiconductor company at the start of the new year.

The move tracked a broader rally in chip stocks that helped U.S. equities end mostly higher on the first trading day of 2026, after a four-session skid, according to Reuters. 1

That matters now because investors are looking for fresh direction after late-December weakness, with economic data and the start of fourth-quarter earnings season poised to reset rate expectations and risk appetite. 2

Astera Labs sells connectivity chips and related products for cloud and artificial-intelligence infrastructure, including PCIe and CXL technology used to move data between processors, accelerators and memory inside servers. 3

The stock traded between $170.30 and $182.88 on Friday, with about 5.7 million shares changing hands, according to market data.

Semiconductor shares were a bright spot across the tape, with the Philadelphia SE Semiconductor index up 4% as stocks such as Nvidia and Intel rose, Reuters reported. 1

Astera last updated investors on November 4, when it reported third-quarter revenue of $230.6 million and guided for fourth-quarter revenue between $245 million and $253 million, a filing showed. 4

Joe Mazzola, head of trading & derivatives strategist at Charles Schwab, described the market as “buy the dip, sell the rip,” while warning investors are watching valuations for AI-linked names. 1

Before Monday’s session, traders’ focus shifts to a busy January calendar, led by U.S. employment data due on January 9 and consumer price inflation data due January 13, Reuters reported. 2

The same Reuters report flagged the approaching fourth-quarter earnings season, with major bank results starting January 13, as investors test whether profit growth justifies elevated index-level valuations. 2

For Astera Labs, the next company-specific catalyst is its quarterly report. Nasdaq lists an estimated earnings date of Feb. 9, 2026, derived from an algorithm based on past reporting patterns; the company has not confirmed a date. 5

On the chart, traders will be watching whether shares hold above Friday’s $170 area and can push through the $183 intraday high, levels that could shape positioning into the next session.

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Citigroup stock closes higher to start 2026 as traders eye jobs data and Citi earnings
Previous Story

Citigroup stock closes higher to start 2026 as traders eye jobs data and Citi earnings

Chevron stock rises as energy kicks off 2026; OPEC+ and Venezuela in focus
Next Story

Chevron stock rises as energy kicks off 2026; OPEC+ and Venezuela in focus

Go toTop